Covered recipient · General Payments record
CARMEN BUSTAMANTE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,594.96
- Reported across 52 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $318.52 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $121.84 | 1 |
| Tandem Diabetes Care, Inc. | $58.76 | 2 |
| Exact Sciences Corporation | $31.77 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $29.84 | 1 |
| Acerta Pharma LLC | $22.80 | 1 |
| Kowa Pharmaceuticals America, Inc. | $18.47 | 1 |
| Amphastar Pharmaceuticals, Inc. | $17.96 | 1 |
| Lilly USA, LLC | $17.08 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amphastar Pharmaceuticals, Inc. | $17.96 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149959679 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.80 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104677481 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $29.84 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118128847 | CMS |
| Exact Sciences Corporation | $31.77 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114603830 | CMS |
| Kowa Pharmaceuticals America, Inc. | $18.47 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113472407 | CMS |
| Lilly USA, LLC | $17.08 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135583968 | CMS |
| Novo Nordisk Inc | $121.84 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100226744 | CMS |
| Tandem Diabetes Care, Inc. | $29.38 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138747493 | CMS |
| Tandem Diabetes Care, Inc. | $29.38 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138747357 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.